Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:23 PM
Ignite Modification Date:
2025-12-24 @ 7:23 PM
NCT ID:
NCT02757703
Eligibility Criteria:
Inclusion Criteria:
* acute hemorrhage from esophageal varice(s)
* portal hypertension attributed by cirrhosis
* age was between 20 and 80 years old
Exclusion Criteria:
* being associated with hepatocellular carcinoma (HCC) of Barcelona-Clinic Liver Cancer (BCLC) \> C
* being associated with severe illness such as chronic obstructive pulmonary disease (COPD), septic shock, cerebral vascular event, acute coronary syndrome and uremia
* with current gastric variceal bleeding
* ever underwent endoscopic injection sclerotherapy (EIS), EVL within 6 month prior to current bleeding episode
* ever received shunt or transjugular intrahepatic porto-systemic stent shunt (TIPS) procedure
* allergic to and/or with contraindications of vasopressors
* pregnancy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
80 Years
Study:
NCT02757703
Study Brief:
Protocol Section:
NCT02757703